JBIO (Jade Biosciences) Research & Development: $109.15 Mil (TTM As of Mar. 2026)


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $22.00
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences Research & Development?

Jade Biosciences JBIO +0.87% 12 Research & Development is $109.15 Mil as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Jade Biosciences's Research & Development for the three months ended in Mar. 2026 was $36.05 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $109.15 Mil.

Jade Biosciences  (NAS:JBIO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Jade Biosciences Research & Development Related Terms

Jade Biosciences Research & Development Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Research & Development Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Research & Development
0.00 93.12

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial 20.02 22.55 22.01 28.54 36.05
JBIO
12GF Score
Jade Biosciences Inc JBIO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $109.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $109.15 Mil mean?
Jade Biosciences (JBIO) has a Research & Development of $109.15 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Jade Biosciences and its competitors.
Is Jade Biosciences' Research & Development too high?
Jade Biosciences' current Research & Development is $109.15 Mil. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Research & Development compare to CRVS and ABSI?
Jade Biosciences' Research & Development of $109.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current Research & Development is $109.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Research & Development of $109.15 Mil. The current Research & Development is $109.15 Mil. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Research & Development is $109.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price